Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 870735Generated: October 30, 2026

Nitrogen → 4-(3-Phenyl-imidazo[1,2-b]pyridazin-6-yl)-piperazine-1-carboxylic acid isopropyl ester monohydrochloride salt

https://huagongshe.com/reaction/870735

Reaction equation

Participants

RoleNameHCIDCharge
ReactantNitrogenHCID 947—
ReactantDichloromethaneHCID 6344—
ReactantPhenylboronic AcidHCID 66827—
ReactantPotassium phosphate, tribasic, monohydrateHCID 22031701—
ReactantHCID 86696444HCID 86696444—
CatalystBis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+)HCID 178418228—
SolventWaterHCID 962—
Solvent1,2-DimethoxyethaneHCID 8071—
Product4-(3-Phenyl-imidazo[1,2-b]pyridazin-6-yl)-piperazine-1-carboxylic acid isopropyl ester monohydrochloride saltHCID 86696442384.7%

Reaction Conditions

Temperature85 °C

Reaction Steps

To a mixture of 4-(3-bromo-imidazo[1,2-b]pyridazin-6-yl)-piperazine-1-carboxylic acid isopropyl ester (330.0 mg, 0.9 mmol), phenyl boronic acid [98-80-8] (131.4 mg, 1.1 mmol), potassium phosphate tribasic monohydrate [27176-10-9] (416.4 mg, 1.8 mmol), and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II), complex with dichloromethane [95464-05-4] (77.1 mg, 0.1 mmol) contained in a 50 mL round bottomed flask was added a solution of 30% (v/v) water in 1,2-dimethoxyethane (25 mL) and a magnetic stir bar. The reaction pot was fitted to a reflux condenser, lowered into an ambient temperature oil bath, and the system taken through 10 evacuation/N2 blanket cycles while being rapidly stirred. The rapidly stirred, N2 blanketed, reaction was heated to an oil bath temperature of 85° C. for 17 h then cooled and partitioned between brine (pH adjusted to 10 with 3N aqueous sodium hydroxide) and ethyl acetate. The phase separated extract was dried (MgSO4) and evaporated to afford an orange oil which was purified by preparative RP-HPLC. Isolated product was dissolved in methanol, diluted with concentrated hydrochloric acid, evaporated to dryness, redissolved in methanol and precipitated by the addition of diethyl ether. Filtration of the precipitate yielded 154.6 mg of 4-(3-phenyl-imidazo[1,2-b]pyridazin-6-yl)-piperazine-1-carboxylic acid isopropyl ester monohydrochloride salt as a white crystalline powder, mp. 232-233° C. (dec). 1H NMR (400 MHz, DMSO-d6) δ ppm 1.22 (d, J=6.32 Hz, 6H) 3.50-3.60 (m, 4H) 3.60-3.70 (m, 4H) 4.77-4.87 (m, 1H) 7.50 (d, J=7.58 Hz, 1H) 7.55-7.71 (m, 2H) 7.77 (d, J=10.11 Hz, 1H) 8.05-8.17 (m, 2H) 8.25 (d, J=10.11 Hz, 1H) 8.54 (s, 1H). 13C NMR (100 MHz, DMSO-d6) δ ppm 21.95, 42.49, 44.98, 68.23, 116.22, 120.94, 122.22, 126.28, 127.18, 128.09, 128.83, 129.05, 132.74, 154.26, 155.80. LRMS (ESI) m/z 366.2 [(M+H)]+, calc'd for C20H23N5O2: 395.44.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08969565B2
Source datasetuspto-grants-2015_03
ORD IDord-770b1104b20c4128913aab22c877f4a8
Source noteuspto-grants-2015_03